Trust Co - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trust Co ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2022$1,0000.0%990.0%0.00%
Q4 2021$1,0000.0%990.0%0.00%
Q3 2021$1,0000.0%990.0%0.00%
-100.0%
Q2 2021$1,0000.0%990.0%0.00%0.0%
Q1 2021$1,0000.0%990.0%0.00%0.0%
Q4 2020$1,0000.0%990.0%0.00%0.0%
Q3 2020$1,0000.0%990.0%0.00%0.0%
Q2 2020$1,0000.0%990.0%0.00%0.0%
Q1 2020$1,0000.0%990.0%0.00%0.0%
Q4 2019$1,0000.0%990.0%0.00%0.0%
Q3 2019$1,0000.0%990.0%0.00%0.0%
Q2 2019$1,0000.0%990.0%0.00%0.0%
Q1 2019$1,0000.0%990.0%0.00%0.0%
Q4 2018$1,0000.0%990.0%0.00%
Q3 2018$1,0000.0%990.0%0.00%
Q2 2018$1,0000.0%990.0%0.00%
Q1 2018$1,0000.0%990.0%0.00%
Q4 2017$1,0000.0%990.0%0.00%
-100.0%
Q3 2017$1,0000.0%990.0%0.00%
Q2 2017$1,0000.0%990.0%0.00%
Q1 2017$1,000990.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders